FDA.reportPublic FDA data

Blistex Stridex Spot and T-Zone Acne ClearGel

Manufacturer
Blistex Inc
Effective date
2015-11-24
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:44:33

Label at a glance#

ProductBlistex Stridex Spot and T-Zone Acne ClearGel
Active ingredientSalicylic Acid
Label structure8 sections

Indications and uses

for the treatment of acne reduces the number of acne pimples and blackheads and allows skin to heal helps prevent new acne pimples from forming

Dosage and administration

clean the skin thoroughly before applying this product cover the entire affected area with a thin layer one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day keep away from eyes, lip...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 2.0% (w/w)

Purpose

OTC - PURPOSE SECTION

Acne medication

Uses

INDICATIONS & USAGE SECTION

  • for the treatment of acne
  • reduces the number of acne pimples and blackheads and allows skin to heal
  • helps prevent new acne pimples from forming

Warnings

WARNINGS SECTION

For external use only

Allergy alert:

do not use this product if you have a known allergy to salicylic acid

When using this product

OTC - WHEN USING SECTION

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • clean the skin thoroughly before applying this product
  • cover the entire affected area with a thin layer one to three times daily
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day
  • keep away from eyes, lips and other mucous membranes

Inactive ingredients

INACTIVE INGREDIENT SECTION

aloe barbadensis leaf juice (decolorized), citric acid, ethylhexylglycerine, hamamelis virginiana (witch hazel) water, phenoxyethanol, purified water, PVM/MA decadiene crosspolymer, sodium borate, sodium hydroxide, tetrasodium EDTA

PRINCIPAL DISPLAY PANEL - 28.35 g Jar Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

STRIDEX®
SALICYLIC ACID 2% W/W ACNE MEDICATION

SPOT & T-ZONE
ACNE CLEARGEL

new!

Focused Treatment For Problem Areas

Net Wt. 1 oz. (28.35 g)

Principal Display Panel - 28.35 g Jar Carton
Principal Display Panel - 28.35 g Jar Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
346298salicylic acid 2 % Topical GelPSN1
1730425Stridex Spot and T-Zone 2 % Topical GelPSN1
1730425salicylic acid 0.02 MG/MG Topical Gel [Stridex]SBD1
346298salicylic acid 0.02 MG/MG Topical GelSCD1
346298salicylic acid 2 % Topical GelSY1
1730425Stridex 0.02 MG/MG Topical GelSY1
1730425Stridex Spot and T-Zone 2 % Topical GelSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
10157-2101-12020-01-31C16284748780-19d75b9d1-038a-f424-e053-dadaa90a57ceBlistex ® Stridex ® Spot and T-Zone Acne ClearGel

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10157-2101-1Blistex Stridex Spot and T-Zone Acne ClearGel1 in 1 CARTONGEL11
10157-2101-1Blistex Stridex Spot and T-Zone Acne ClearGel28.35 g in 1 JARGEL28.351

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10157-2101BLISTEX STRIDEX SPOT AND T-ZONE ACNE CLEARGEL (SALICYLIC ACID) GEL [BLISTEX INC]1Legacy NDC, 2 package rows20160104_ff6dc5e5-08b4-4259-922a-7bb71dc054eb.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10157-210110157-2101-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Name, UNII, Kind table
NameUNIIKind
Salicylic AcidO414PZ4LPZACTIB
WATER059QF0KO0RIACT
HAMAMELIS VIRGINIANA TOP WATERNT00Y05A2VIACT
SODIUM BORATE91MBZ8H3QOIACT
SODIUM HYDROXIDE55X04QC32IIACT
PHENOXYETHANOLHIE492ZZ3TIACT
EDETATE SODIUMMP1J8420LUIACT
ETHYLHEXYLGLYCERIN147D247K3PIACT
CITRIC ACID MONOHYDRATE2968PHW8QPIACT
ALOE VERA LEAFZY81Z83H0XIACT
MALEIC ANHYDRIDEV5877ZJZ25IACT
1,9-DECADIENE2KWZ01G244IACT
METHYL VINYL ETHERG2OHX46576IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
be0c53be-99a3-442f-a3d3-9ffa8b959bd1ff6dc5e5-08b4-4259-922a-7bb71dc054eb2015-11-24WarningsExact identifier
spl id: be0c53be-99a3-442f-a3d3-9ffa8b959bd1
spl set id: ff6dc5e5-08b4-4259-922a-7bb71dc054eb

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.